Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mink Therapeutics Inc (INKT)

Mink Therapeutics Inc (INKT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mink Therapeutics Inc 149 Fifth Avenue Suite 500 New York NY 10010 USA

www.minktherapeutics.com Employees: 23 P: 212-994-8250

Sector:

Medical

Description:

MiNK Therapeutics Inc. is a clinical stage biotechnology company pioneering the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T cell therapies to treat cancer and other immune-mediated diseases. MiNK Therapeutics Inc. is headquartered in New York.

Key Statistics

Overview:

Market Capitalization, $K 51,871
Enterprise Value, $K 52,211
Shares Outstanding, K 4,694
Float, K 3,639
% Float 77.52%
Short Interest, K 32
Short Float 0.68%
Days to Cover 3.28
Short Volume Ratio 0.61
% of Insider Shareholders 22.48%
% of Institutional Shareholders 2.87%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -9,510 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -2,890 K
EBIT, $ -11,160 K
EBITDA, $ -10,940 K

Growth:

1-Year Return 17.70%
3-Year Return -47.68%
5-Year Return 0.00%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.65 on 11/14/25
Next Earnings Date 03/17/26
Earnings Per Share ttm -3.03
EPS Growth vs. Prev Qtr 38.68%
EPS Growth vs. Prev Year -30.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 01/28/25

INKT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -180.14%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -2.94
Interest Coverage -1.58
60-Month Beta 0.34
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar